Gatske Nieuwenhuyzen-de Boer

11PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersPlasma physics; fusion plasmas; electrical dischargesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 27, 2024
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients.

Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben Boers

|Aug 12, 2023
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients.

Gatske M Nieuwenhuyzen-de Boer, Hanane Aamran, Caroline B van den Berg

|May 16, 2023
Plasma Device Functions and Tissue Effects in the Female Pelvis-A Systematic Review.

Nick J van de Berg, Gatske M Nieuwenhuyzen-de Boer, Xu Shan Gao

|Jan 08, 2023
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study.

Gatske M Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere

|Oct 05, 2022
Cost Study of the PlasmaJet Surgical Device Versus Conventional Cytoreductive Surgery in Patients With Advanced-Stage Ovarian Cancer.

Gatske M Nieuwenhuyzen-de Boer, Alexandra J L M Geraerds, Marieke H van der Linden

Pageof 2